Prognostic value of left atrial strain in heart failure with reduced ejection fraction

Back

ESC Professional Premium Access

Prognostic value of left atrial strain in heart failure with reduced ejection fraction

Session: HFrEF pathophysiology

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor B. Tas Ozbek (Copenhagen, DK) Doctor M. Sengelov (Hellerup, DK)

Event: ESC Congress 2023

Congress Presentation

About the speakers

Doctor Burcu Tas Ozbek

Gentofte University Hospital, Copenhagen (Denmark)

0 follower

Doctor Morten Sengelov

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

1 presentation

0 follower

6 more presentations in this session

Repetitive LevosimenDan infusions fOR patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized LeoDOR trial

Speaker: Associate Professor G. Polzl (Innsbruck, AT)

Deep learning model to identify potential occurrence of reduced LVEF in patients with implantable loop recorders

Speaker: Doctor J. Howard (London, GB)

Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

Speaker: Doctor J. Butler (Dallas, US)

The effect of iron deficiency treatment with intravenous ferric carboxymaltose on the arrhythmic burden of patients with HFrEF and cardiac implantable electronic devices

Speaker: Mr A. Tsarouchas (Thessaloniki, GR)

Prognostic value of three iron deficiency definitions in patients with advanced heart failure

Speaker: Doctor J. Reinhold (Norwich, GB)

Access the full session

HFrEF pathophysiology

Speakers: Doctor B. Tas Ozbek, Doctor M. Sengelov, Associate Professor G. Polzl, Doctor J. Howard, Doctor J. Butler...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Prognostic value of left atrial strain in heart failure with reduced ejection fraction

About the speakers

Doctor Burcu Tas Ozbek

Doctor Morten Sengelov

6 more presentations in this session

Repetitive LevosimenDan infusions fOR patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized LeoDOR trial

Deep learning model to identify potential occurrence of reduced LVEF in patients with implantable loop recorders

Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

The effect of iron deficiency treatment with intravenous ferric carboxymaltose on the arrhythmic burden of patients with HFrEF and cardiac implantable electronic devices

Prognostic value of three iron deficiency definitions in patients with advanced heart failure

Access the full session

HFrEF pathophysiology

About the event

ESC Congress 2023

ESC 365 is supported by